Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double‐blind, placebo‐controlled study

Xu, W.‐M.; Cui, Y.‐T.; Wang, L.; Yang, H.; Liang, Z.‐Q.; Li, X.‐M.; Zhang, S.‐L.; Qiao, F.‐Y.; Campbell, F.; Chang, C.‐N.; Gardner, S.; Atkins, M.

doi:10.1111/j.1365-2893.2008.01056.x

Public

Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double‐blind, placebo‐controlled study

Shared by NobleBlocks on Jan 28, 2009 • 12:00 AM UTC

Authors:

W.‐M. Xu

Y.‐T. Cui

L. Wang

Abstract

Summary. This randomized, double‐blind, placebo‐controlled study evaluated whether lamivudine given during late pregnancy can reduce hepatitis B virus (HBV) perinatal transmission in highly viraemic mothers. Mothers were randomized to either lamivudine 100 mg or placebo from week 32 of gestation to ...

Discussions